Matches in Nanopublications for { ?s ?p "[We have found that methylated MGMT, CDKN2A, and MLH1 occur in 49%, 34%, and 7% of adenomas and in 5%, 10%, and 7% of hyperplastic polyps, respectively, and that they are more common in histologically advanced adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- assertion description "[We have found that methylated MGMT, CDKN2A, and MLH1 occur in 49%, 34%, and 7% of adenomas and in 5%, 10%, and 7% of hyperplastic polyps, respectively, and that they are more common in histologically advanced adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP308374.RAGvY_wnpJVqPx8f_RIYITfVDY6XHwF9ZMiyCspyHEo_8130_assertion description "[We have found that methylated MGMT, CDKN2A, and MLH1 occur in 49%, 34%, and 7% of adenomas and in 5%, 10%, and 7% of hyperplastic polyps, respectively, and that they are more common in histologically advanced adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP308374.RAGvY_wnpJVqPx8f_RIYITfVDY6XHwF9ZMiyCspyHEo_8130_provenance.
- assertion description "[We have found that methylated MGMT, CDKN2A, and MLH1 occur in 49%, 34%, and 7% of adenomas and in 5%, 10%, and 7% of hyperplastic polyps, respectively, and that they are more common in histologically advanced adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We have found that methylated MGMT, CDKN2A, and MLH1 occur in 49%, 34%, and 7% of adenomas and in 5%, 10%, and 7% of hyperplastic polyps, respectively, and that they are more common in histologically advanced adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP480774.RAenESUyN3frwE4vhzPSHIkHNXs-HpJ_mB5F-E3Dkq4cA130_assertion description "[We have found that methylated MGMT, CDKN2A, and MLH1 occur in 49%, 34%, and 7% of adenomas and in 5%, 10%, and 7% of hyperplastic polyps, respectively, and that they are more common in histologically advanced adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480774.RAenESUyN3frwE4vhzPSHIkHNXs-HpJ_mB5F-E3Dkq4cA130_provenance.
- NP480780.RAScZkFlaWkS3QrD7HQgmJQVoSfnsEGhh1Lg3oL9Kq1fc130_assertion description "[We have found that methylated MGMT, CDKN2A, and MLH1 occur in 49%, 34%, and 7% of adenomas and in 5%, 10%, and 7% of hyperplastic polyps, respectively, and that they are more common in histologically advanced adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480780.RAScZkFlaWkS3QrD7HQgmJQVoSfnsEGhh1Lg3oL9Kq1fc130_provenance.
- NP847525.RAOjQpCEfVGzCRiL-mc539NfqR7YYEmKMK4Rl4yUI032c130_assertion description "[We have found that methylated MGMT, CDKN2A, and MLH1 occur in 49%, 34%, and 7% of adenomas and in 5%, 10%, and 7% of hyperplastic polyps, respectively, and that they are more common in histologically advanced adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP847525.RAOjQpCEfVGzCRiL-mc539NfqR7YYEmKMK4Rl4yUI032c130_provenance.
- NP558410.RA4DNGAhWCetwvalV0g3XHrzzHsTPfe8uT8gaPJYRgy1w130_assertion description "[We have found that methylated MGMT, CDKN2A, and MLH1 occur in 49%, 34%, and 7% of adenomas and in 5%, 10%, and 7% of hyperplastic polyps, respectively, and that they are more common in histologically advanced adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP558410.RA4DNGAhWCetwvalV0g3XHrzzHsTPfe8uT8gaPJYRgy1w130_provenance.
- NP480782.RAHreQGPWFriFxD08zVFK268PwybJKHTkYGaaEBwR-_sc130_assertion description "[We have found that methylated MGMT, CDKN2A, and MLH1 occur in 49%, 34%, and 7% of adenomas and in 5%, 10%, and 7% of hyperplastic polyps, respectively, and that they are more common in histologically advanced adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480782.RAHreQGPWFriFxD08zVFK268PwybJKHTkYGaaEBwR-_sc130_provenance.